Carna Biosciences, Inc.

Carna Biosciences, Inc. is a clinical-stage biopharmaceutical company based in Kobe, Japan, that researches and develops drug therapies for unmet medical needs. It offers kinase proteins and other protein products, along with biochemical and cell-based assay services. The company is developing monzosertib, docirbrutinib, and sofnobrutinib for cancer and immune-related conditions. Incorporated in 2003, it is headquartered in Kobe, Japan.